All News

The drug is a rare FDA-approved liquid formulation that treats ulcers and lowers risk of gastrointestinal bleeding in chronically ill patients.

The new feature automatically applies manufacturer-sponsored coupons directly to an eligible patient’s order. So far, only a few pharma companies have made their coupons available through Amazon.

Your weekly roundup of the latest news from Drug Topics®.

In the world of medication, packaging can make all the difference. Sead Ferhatovic from Jones Healthcare Group joins Drug Topics to talk about blister packs, automation in prescription packaging, and more.

The AVMA is working with lawmakers to help increase the numbers of animal drug approvals.

The drug, called Tauramox, is the first generic moxidectin injectable solution to control internal and external parasites.

The suit alleges that Express Scripts, Prime and Prime customer Humana Pharmacy Solutions are able to share drug pricing and rebate information to increase prices for insulins, biologics and cancer drugs.

However, the researches make clear that their findings should not be construed as an endorsement of irresponsible or liberal opioid use.

If approved, Perrigo’s Opill would be the first nonprescription birth control pill ever.

Sponsored by Provetica, Modulis for Cats contains the same active ingredient, concentration and dosage form as the Atopica for Cats brand product.

Though unlikely to pass this year, opponents say the proposal is nonetheless amplifying the spread of false claims and sowing distrust of medical professionals.

According to a recent study, the diabetes medication semaglutide is more effective as a 25 mg or 50 mg dose on its own, rather than a 14 mg add-on dose with other medications.

The drug, branded as Rezzayo, is the first FDA-approved invasive candidiasis treatment in over a decade.

The drug, called Leniolisib, is the first and only treatment approved in the United States for APDS, a rare primary immunodeficiency.

The risk of developing breast cancer was greater in women who are currently using or recently used progestogen-only contraceptives, a recent study showed.

The drug Leniolisib, now with the brand name Joenja, treats APDA, a genetic disorder that impairs the immune system. Its annual list price will be $547,500.

Vitamin D supplementation may be an effective and safe adjunctive prophylactic therapy to topiramate for children who experience migraine attacks, showed a study conducted in Saudi Arabia.

Speakers at the 2023 virtual Value-Based Insurance Design Summit discussed government programs and company initiatives to advance health equity, as well as the role of research and advocacy to achieve pharmacoequity.

Rural communities are often left without adequate assistance in times of need, but pharmacists can provide crucial care.

Investigators found a robust antigen-specific antibody response against HIV and Zika virus between mothers and newborns in a model using rabbits.

The British pharma giant has teamed up with Johnson for a promotional campaign as they approach the finish line of an RSV vaccine.

All children included in the analysis with presymptomatic SMA achieved swallowing, oral nutrition, and airway protection outcomes.

Regulatory officials said additional requirements are needed in order to approve the drug, which is under review for treatment of myelofibrosis, polycythemia vera, and graft-versus-host disease.

The proposed legislation, sponsored by Chuck Grassley and Maria Cantwell, aims to necessitate transparency from PBMs.

According to a study, patients are frequently prescribed broad-spectrum antibiotics instead of narrowly tailored antibiotics, which would be more optimized to treat them.

Dupilumab met both its primary and key secondary endpoints in a phase 3 trial, demonstrating efficacy as a potential treatment for atopic hand and foot dermatitis.

The drug, called Lumisight, is an optical imaging agent that detects cancerous tissue during initial lumpectomy to allow for a more complete resection. An NDA has been submitted to the FDA.

Evkeeza, which treats a rare form of high cholesterol, is now approved for patients as young of 5 years.

Here’s a look back at the cancer drugs that gained FDA approval in the winter of 2023.